Yıl: 2021 Cilt: 30 Sayı: 3 Sayfa Aralığı: 193 - 198 Metin Dili: İngilizce DOI: 10.5152/turkjnephrol.2021.4657 İndeks Tarihi: 27-10-2021

Determinants of Mortality Among Elderly Subjects with Chronic Kidney Disease

Öz:
Objective: Studies on predictors of mortality among elderly chronic kidney disease (CKD) patients have conflicting results.We aimed to assess the factors related to mortality in CKD versus non-CKD elderly subjects.Methods: Medical records of consecutive elderly subjects presented to geriatrics outpatient clinics were retrospectivelysearched. Logistic regression models were set in order to determine independent predictors of mortality.Results: The median age was 73 (67-80) years, and 837 (67.9%) were female. CKD constituted 21.9% of the cohort. Duringthe follow-up of 3 to 4 years, 7.2% of the patients died. In the CKD cohort, older age (per year, OR 1.12, 95% CI 1.01-1.25, P= .040) and serum uric acid levels (per 1 mg/dL increase, OR 1.74, 95% CI 1.12-2.69, P = .013) were associated with a higherrisk of mortality while serum albumin (per 1 g/dL increase, OR 0.08, 95% CI 0.01-0.52, P = .008) and vitamin D levels (per1 ng/mL increase, OR 0.77, 95% CI 0.62-0.96, P = .019) were associated with a lower risk of mortality in the multivariateregression model.Conclusion: Older age, lower serum albumin and vitamin D levels, and higher serum uric acid levels are independent predictors of mortality in outpatient elderly subjects with CKD.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Eckardt KU, Coresh J, Devuyst O, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382(9887):158-169. [CrossRef]
  • 2. Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17(7):2034-2047. [CrossRef]
  • 3. Thompson S, James M, Wiebe N, Alberta Kidney Disease Network et al. Cause of death in patients with reduced kidney function. J Am Soc Nephrol. 2015;26(10):2504-2511. [CrossRef]
  • 4. Charytan DM, Lewis EF, Desai AS, et al. Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce cardiovascular Events With Aranesp Therapy (TREAT). Am J Kidney Dis. 2015;66(3):429-440. [CrossRef]
  • 5. Landray MJ, Emberson JR, Blackwell L, et al. Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study. Am J Kidney Dis. 2010;56(6):1082-1094. [CrossRef]
  • 6. Tsur N, Menashe I, Haviv YS. Risk Factors Before Dialysis Predominate as Mortality Predictors in Diabetic Maintenance Dialysis patients [sci rep.:10633]. Sci Rep. 2019;9(1):10633. [CrossRef]
  • 7. Floege J, Gillespie IA, Kronenberg F, et al. Development and validation of a predictive mortality risk score from a European hemodialysis cohort. Kidney Int. 87(5):996-1008. [CrossRef]
  • 8. KDIGO CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1-150.
  • 9. Levey AS, Stevens LA, Schmid CH, et al. CKD-EPI (chronic kidney disease epidemiology collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-612. [CrossRef]
  • 10. Suliman ME, Johnson RJ, García-López E, et al. J-shaped mortality relationship for uric acid in CKD. Am J Kidney Dis. 2006;48(5):761- 771. [CrossRef]
  • 11. Kanbay M, Yilmaz MI, Sonmez A, et al. Serum uric acid independently predicts cardiovascular events in advanced nephropathy. Am J Nephrol. 2012;36(4):324-331. [CrossRef]
  • 12. Kleber ME, Delgado G, Grammer TB, et al. Uric acid and cardiovascular events: A Mendelian randomization study. J Am Soc Nephrol. 2015;26(11):2831-2838. [CrossRef]
  • 13. Luo Q, Xia X, Li B, et al. Serum uric acid and cardiovascular mortality in chronic kidney disease: a meta-analysis. BMC Nephrol. 2019;20(1):18. [CrossRef]
  • 14. Xia X, Luo Q, Li B, et al. Serum uric acid and mortality in chronic kidney disease: A systematic review and meta-analysis. Metabolism. 2016;65(9):1326-1341. [CrossRef]
  • 15. Madero M, Sarnak MJ, Wang X, et al. Uric acid and long-term outcomes in CKD. Am J Kidney Dis. 2009;53(5):796-803. [CrossRef]
  • 16. Tsai CW, Chiu HT, Huang HC, et al. Uric acid predicts adverse outcomes in chronic kidney disease: a novel insight from trajectory analyses. Nephrol Dial Transplant. 2018;33(2):231-241. [CrossRef]
  • 17. Navaneethan SD, Beddhu S. Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease. Nephrol Dial Transplant. 2009;24(4):1260-1266. [CrossRef]
  • 18. Badve SV, Pascoe EM, Tiku A, et al. Effects of allopurinol on the progression of chronic kidney disease. N Engl J Med. 2020;382(26):2504-2513. [CrossRef]
  • 19. Doria A, Galecki AT, Spino C, PERL Study Group et al. Serum urate lowering with allopurinol and kidney function in Type 1 diabetes. N Engl J Med. 382(26):2493-2503. [CrossRef]
  • 20. Liu X, Wang H, Ma R et al. The urate-lowering efficacy and safety of febuxostat versus allopurinol in Chinese patients with asymptomatic hyperuricemia and with chronic kidney disease stages 3-5. Clin Exp Nephrol. 2019;23(3):362-370. [CrossRef]. Epub 2018 Oct 5. [CrossRef].
  • 21. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2011). 2017;7(1):1-59. [CrossRef]
  • 22. Chonchol M, Scragg R. 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int. 2007;71(2):134-139. [CrossRef]
  • 23. Delanaye P, Jager KJ, Bökenkamp A, et al. CKD: A call for an ageadapted definition. J Am Soc Nephrol. 2019;30(10):1785-1805. [CrossRef]
APA Heybeli C, SOYSAL P (2021). Determinants of Mortality Among Elderly Subjects with Chronic Kidney Disease. , 193 - 198. 10.5152/turkjnephrol.2021.4657
Chicago Heybeli Cihan,SOYSAL Pınar Determinants of Mortality Among Elderly Subjects with Chronic Kidney Disease. (2021): 193 - 198. 10.5152/turkjnephrol.2021.4657
MLA Heybeli Cihan,SOYSAL Pınar Determinants of Mortality Among Elderly Subjects with Chronic Kidney Disease. , 2021, ss.193 - 198. 10.5152/turkjnephrol.2021.4657
AMA Heybeli C,SOYSAL P Determinants of Mortality Among Elderly Subjects with Chronic Kidney Disease. . 2021; 193 - 198. 10.5152/turkjnephrol.2021.4657
Vancouver Heybeli C,SOYSAL P Determinants of Mortality Among Elderly Subjects with Chronic Kidney Disease. . 2021; 193 - 198. 10.5152/turkjnephrol.2021.4657
IEEE Heybeli C,SOYSAL P "Determinants of Mortality Among Elderly Subjects with Chronic Kidney Disease." , ss.193 - 198, 2021. 10.5152/turkjnephrol.2021.4657
ISNAD Heybeli, Cihan - SOYSAL, Pınar. "Determinants of Mortality Among Elderly Subjects with Chronic Kidney Disease". (2021), 193-198. https://doi.org/10.5152/turkjnephrol.2021.4657
APA Heybeli C, SOYSAL P (2021). Determinants of Mortality Among Elderly Subjects with Chronic Kidney Disease. Turkish journal of nephrology (Online), 30(3), 193 - 198. 10.5152/turkjnephrol.2021.4657
Chicago Heybeli Cihan,SOYSAL Pınar Determinants of Mortality Among Elderly Subjects with Chronic Kidney Disease. Turkish journal of nephrology (Online) 30, no.3 (2021): 193 - 198. 10.5152/turkjnephrol.2021.4657
MLA Heybeli Cihan,SOYSAL Pınar Determinants of Mortality Among Elderly Subjects with Chronic Kidney Disease. Turkish journal of nephrology (Online), vol.30, no.3, 2021, ss.193 - 198. 10.5152/turkjnephrol.2021.4657
AMA Heybeli C,SOYSAL P Determinants of Mortality Among Elderly Subjects with Chronic Kidney Disease. Turkish journal of nephrology (Online). 2021; 30(3): 193 - 198. 10.5152/turkjnephrol.2021.4657
Vancouver Heybeli C,SOYSAL P Determinants of Mortality Among Elderly Subjects with Chronic Kidney Disease. Turkish journal of nephrology (Online). 2021; 30(3): 193 - 198. 10.5152/turkjnephrol.2021.4657
IEEE Heybeli C,SOYSAL P "Determinants of Mortality Among Elderly Subjects with Chronic Kidney Disease." Turkish journal of nephrology (Online), 30, ss.193 - 198, 2021. 10.5152/turkjnephrol.2021.4657
ISNAD Heybeli, Cihan - SOYSAL, Pınar. "Determinants of Mortality Among Elderly Subjects with Chronic Kidney Disease". Turkish journal of nephrology (Online) 30/3 (2021), 193-198. https://doi.org/10.5152/turkjnephrol.2021.4657